Gordon, E M <br/><br/>
Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice.  [electronic resource] 

 -  Human gene therapy  Jan 2001 
 - 193-204 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/104303401750061258  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Collagen--genetics<br/>Cyclin G<br/>Cyclin G1<br/>Cyclins--genetics<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Humans<br/>In Situ Nick-End Labeling<br/>Infusions, Intravenous<br/>Mice<br/>Mice, Nude<br/>Retroviridae--genetics<br/>Skin Neoplasms--metabolism<br/>Transplantation, Heterologous<br/>beta-Galactosidase--metabolism